Access To Medicine Index Finds Progress In Pharma’s Efforts
Monday, 14 November 2016
Intellectual Property Watch
Catherine Saez reports on the main findings of the 2016 Access to Medicine Index, focusing on the industry analysis on TRIPS and compulsory licenses.
The Access to Medicine Index 2016 was published today, analysing the top 20 research-based pharmaceutical companies. The index looks at how those companies make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. The index found progress in companies’ efforts to improve access but little support for flexibilities enshrined in international trade rules.
The index highlights best and innovative practices, and areas where progress has been made and where action is still required. It has been published every two years since 2008.